Aqr Capital Management LLC Nektar Therapeutics Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Aqr Capital Management LLC holds 501,590 shares of NKTR stock, worth $466,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
501,590
Holding current value
$466,478
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.11 - $1.48 $556,764 - $742,353
501,590 New
501,590 $652,000
Q1 2024

May 15, 2024
SELL
$0.49 - $0.96 $492,237 - $964,383
-1,004,566 Reduced 69.98%
430,983 $400,000
Q4 2023

Feb 14, 2024
SELL
$0.42 - $0.57 $936,900 - $1.27 Million
-2,230,715 Reduced 60.84%
1,435,549 $803,000
Q3 2023

Nov 14, 2023
BUY
$0.51 - $1.05 $430,768 - $886,876
844,644 Added 29.93%
3,666,264 $2.2 Million
Q2 2023

Aug 14, 2023
BUY
$0.53 - $1.03 $44,303 - $86,098
83,591 Added 3.05%
2,821,620 $1.64 Million
Q1 2023

May 15, 2023
BUY
$0.64 - $3.15 $1.47 Million - $7.23 Million
2,295,171 Added 518.26%
2,738,029 $1.92 Million
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $450,696 - $950,237
222,018 Added 100.53%
442,858 $1 Million
Q3 2022

Nov 14, 2022
SELL
$3.04 - $5.14 $847,406 - $1.43 Million
-278,752 Reduced 55.8%
220,840 $704,000
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $1.01 Million - $1.96 Million
317,435 Added 174.26%
499,592 $1.9 Million
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $757,773 - $2.5 Million
182,157 New
182,157 $982,000
Q3 2019

Nov 14, 2019
SELL
$16.91 - $36.27 $12.8 Million - $27.4 Million
-755,535 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$31.0 - $36.3 $14.7 Million - $17.2 Million
-474,557 Reduced 38.58%
755,535 $26 Million
Q1 2019

May 14, 2019
BUY
$31.58 - $46.35 $4.66 Million - $6.84 Million
147,523 Added 13.63%
1,230,092 $41 Million
Q4 2018

Feb 14, 2019
BUY
$30.43 - $56.65 $22.3 Million - $41.4 Million
731,600 Added 208.45%
1,082,569 $35.6 Million
Q3 2018

Nov 15, 2018
BUY
$46.46 - $68.49 $9.81 Million - $14.5 Million
211,132 Added 150.98%
350,969 $21.4 Million
Q2 2018

Aug 14, 2018
SELL
$46.25 - $104.45 $4.14 Million - $9.34 Million
-89,436 Reduced 39.01%
139,837 $6.83 Million
Q1 2018

May 15, 2018
BUY
$57.4 - $108.44 $3.22 Million - $6.08 Million
56,034 Added 32.34%
229,273 $24.4 Million
Q4 2017

Feb 14, 2018
BUY
$23.02 - $60.5 $3.99 Million - $10.5 Million
173,239
173,239 $10.3 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email